SCHEMBL6530152

SCHEMBL6530152

COc1cccc2nc(N)n(CCN3CCOCC3)c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.50
TSHR P16473 1/20 0.50
ADORA2A P29274 1/20 0.46
LMNA P02545 4/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
ALDH1A1 P00352 6/20 0.44
GAA P10253 5/20 0.44
MAPT P10636 3/20 0.44
CNR2 P34972 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CNR1 P21554 1/20 0.44
POLB P06746 1/20 0.44
HIF1A Q16665 1/20 0.44
KDM4E B2RXH2 4/20 0.44
HPGD P15428 4/20 0.44
S1PR2 O95136 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19437553 0.78 STING1 (0.57) CYP2D6LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL20797417 0.75 CASR (0.43) CYP2D6TSHRLMNACYP1A2CYP3A4
SCHEMBL3599686 0.75 LMNA (0.68) CYP2D6TSHRLMNACYP1A2ALDH1A1
SCHEMBL6505339 0.74 KDM4E (0.69) TSHRLMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL19437519 0.73 STING1 (0.62) CYP2D6LMNAALDH1A1GAAMAPT
SCHEMBL5459067 0.72 PRMT5 (0.60) LMNACYP3A4ALDH1A1GAAMAPT
SCHEMBL11712420 0.69 CXCR4 (0.66) CYP2D6TSHRLMNACYP1A2ALDH1A1
SCHEMBL17891869 0.69 ADORA2A (0.68) ADORA2A
SCHEMBL2362286 0.68 TLR8 (0.60) TSHRLMNAALDH1A1GAAMAPT
SCHEMBL2011534 0.68 CYP2D6 (0.60) CYP2D6TSHRSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005021547-A2 HETEROCYCLIC CANNABINOID CB2 RECEPTOR ANTAGONISTS PHARMAXIS PTY LTD. (AU) 2005-03-10 WO disclosed